BEAM vs FAST · rev $63.5M vs P/E 43, rev $7.55B
Beam Therapeutics Inc (BEAM) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
BEAM currently screens at market cap $2.01B. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the BEAM and FAST stock pages for the full models.
Not investment advice.